Antibody buffering of a ligand in vivo

द्वारा O'Hear, Carol E., Foote, Jefferson
प्रकाशित 2005

Anti-CD33 chimeric antigen receptor targeting of acute myeloid leukemia

द्वारा O’Hear, Carol, Heiber, Joshua F., Schubert, Ingo, Fey, Georg, Geiger, Terrence L.
में प्रकाशित Haematologica (2015)

Tumor immune microenvironment and genomic evolution in a patient with metastatic triple negative breast cancer and a complete response to atezolizumab

द्वारा Molinero, Luciana, Li, Yijin, Chang, Ching-Wei, Maund, Sophia, Berg, Maureen, Harrison, Jeanne, Fassò, Marcella, O’Hear, Carol, Hegde, Priti, Emens, Leisha A.
में प्रकाशित J Immunother Cancer (2019)

PI3K orchestration of the in vivo persistence of chimeric antigen receptor-modified T cells

द्वारा Zheng, Wenting, O’Hear, Carol E., Alli, Rajshekhar, Basham, Jacob H., Abdelsamed, Hosaam, Palmer, Lance E., Jones, Lindsay L., Youngblood, Ben, Geiger, Terrence L.
में प्रकाशित Leukemia (2018)

Gemtuzumab Ozogamicin Can Reduce Minimal Residual Disease in Patients With Childhood Acute Myeloid Leukemia

द्वारा O’Hear, Carol, Inaba, Hiroto, Pounds, Stanley, Shi, Lei, Dahl, Gary, Bowman, W. Paul, Taub, Jeffrey W., Pui, Ching-Hon, Ribeiro, Raul C., Coustan-Smith, Elaine, Campana, Dario, Rubnitz, Jeffrey E.
में प्रकाशित Cancer (2013)

Association of Cancer Immunotherapy With Acute Macular Neuroretinopathy and Diffuse Retinal Venulitis

द्वारा Emens, Leisha A., Davis, S. Lindsey, Oliver, Scott C. N., Lieu, Christopher H., Reddy, Ashvini, Solomon, Sharon, He, Lingmin, Morley, Roland, Fassò, Marcella, Pirzkall, Andrea, Patel, Hina, O’Hear, Carol, Ferrara, Daniela
में प्रकाशित JAMA Ophthalmol (2018)

Atezolizumab (MPDL3280A) Monotherapy for Patients With Metastatic Urothelial Cancer: Long-term Outcomes From a Phase 1 Study

द्वारा Petrylak, Daniel P., Powles, Thomas, Bellmunt, Joaquim, Braiteh, Fadi, Loriot, Yohann, Morales-Barrera, Rafael, Burris, Howard A., Kim, Joseph W., Ding, Beiying, Kaiser, Constanze, Fassò, Marcella, O’Hear, Carol, Vogelzang, Nicholas J.
में प्रकाशित JAMA Oncol (2018)

Immune biomarkers associated with clinical benefit from atezolizumab (MPDL3280a; anti-PD-L1) in advanced urothelial bladder cancer (UBC)

द्वारा Powles, Thomas, Nickles, Dorothee, Van Allen, Eliezer, Chappey, Colombe, Zou, Wei, Kowanetz, Marcin, Kadel, Edward, Denker, Mitchell, Boyd, Zachary, Vogelzang, Nicholas, Kim, Joseph, Bellmunt, Joaquim, Loriot, Yohann, Drake, Charles G, O'Hear, Carol, Fasso, Marcella, Hegde, Priti, Mariathasan, Sanjeev
में प्रकाशित J Immunother Cancer (2015)

Long-term Clinical Outcomes and Biomarker Analyses of Atezolizumab Therapy for Patients With Metastatic Triple-Negative Breast Cancer: A Phase 1 Study

द्वारा Emens, Leisha A., Cruz, Cristina, Eder, Joseph Paul, Braiteh, Fadi, Chung, Cathie, Tolaney, Sara M., Kuter, Irene, Nanda, Rita, Cassier, Philippe A., Delord, Jean-Pierre, Gordon, Michael S., ElGabry, Ehab, Chang, Ching-Wei, Sarkar, Indrani, Grossman, William, O’Hear, Carol, Fassò, Marcella, Molinero, Luciana, Schmid, Peter
में प्रकाशित JAMA Oncol (2018)